StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report released on Saturday morning. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
NYSE:CO opened at $1.35 on Friday. The firm has a 50-day moving average of $1.50 and a 200-day moving average of $1.36. The company has a market cap of $164.09 million, a PE ratio of 2.11 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.
Global Cord Blood Company Profile
Featured Stories
- Five stocks we like better than Global Cord Blood
- What does consumer price index measure?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is the S&P 500 and How It is Distinct from Other Indexes
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Evaluate a Stock Before BuyingÂ
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.